Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.58 |
| ▸ | PARP10 | Q53GL7 | 10/20 | 0.47 |
| ▸ | PARP1 | P09874 | 9/20 | 0.47 |
| ▸ | PARP11 | Q9NR21 | 6/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.47 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.46 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.46 |
| ▸ | PRKCG | P05129 | 1/20 | 0.46 |
| ▸ | PRKCB | P05771 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | PRKCH | P24723 | 1/20 | 0.46 |
| ▸ | PRKCI | P41743 | 1/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.46 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.46 |
| ▸ | USP7 | Q93009 | 1/20 | 0.46 |
| ▸ | USP21 | Q9UK80 | 1/20 | 0.46 |
| ▸ | CDC7 | O00311 | 2/20 | 0.46 |
| ▸ | CDK9 | P50750 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL25205058 | 0.91 | MAP2K1 (0.50) | MAP2K1PARP10PARP1PARP11PDPK1 | |
| Trifluoroacetic Acid SCHEMBL15687819 | 0.85 | MAP2K1 (0.45) | MAP2K1PARP10PARP1PARP11PDPK1 | |
| SCHEMBL5320283 | 0.78 | — | — | |
| SCHEMBL6891945 | 0.78 | MAP2K1 (0.72) | MAP2K1PARP10PARP1PARP11PDPK1 | |
| Hydrochloric Acid SCHEMBL5337159 | 0.77 | CA12 (0.42) | MAP2K1PARP10PARP1PARP11PDPK1 | |
| Aldisin SCHEMBL7844916 | 0.73 | MAP2K1 (1.00) | MAP2K1PARP10PARP1PARP11PDPK1 | |
| SCHEMBL24282441 | 0.71 | — | — | |
| SCHEMBL689700 | 0.68 | MAP2K1 (0.46) | MAP2K1PARP1PRKCIMAPK1PLK1 | |
| SCHEMBL15468004 | 0.68 | MAP2K1 (0.60) | MAP2K1PARP10PARP1PARP11PDPK1 | |
| SCHEMBL13222116 | 0.67 | MAP2K1 (0.62) | MAP2K1PARP10PARP1PARP11PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3959211-B1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS | BAYER AG (DE) | 2026-02-18 | — | — | EP | claimed |
| EP-4592283-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | Joint Stock Company "Biocad" (RU) | 2025-07-30 | — | — | EP | claimed |
| CN-117946100-A | 4H-pyrrolo [3,2-c ] pyridin-4-one compounds | 拜耳股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2024063670-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | Акционерное общество "БИОКАД" | 2024-03-28 | — | — | WO | claimed |
| CN-114127064-B | 4H-pyrrolo [3,2-c ] pyridin-4-one compounds | 拜耳股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116997549-A | Pyrrolo [3,2-C ] pyridin-4-one derivatives for the treatment of cancer | 蝎子疗法股份有限公司 | 2023-11-03 | — | — | CN | claimed |
| EP-4126861-A1 | 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | Bayer Aktiengesellschaft (DE) | 2023-02-08 | — | — | EP | claimed |
| EP-3959212-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS | Bayer Aktiengesellschaft (DE) | 2022-03-02 | — | — | EP | claimed |
| EP-3958865-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2022-03-02 | — | — | EP | claimed |
| EP-3959211-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS | Bayer Aktiengesellschaft (DE) | 2022-03-02 | — | — | EP | claimed |
| CN-114127064-A | 4H-pyrrolo [3,2-c ] pyridin-4-one compounds | 拜耳股份有限公司 | 2022-03-01 | — | — | CN | claimed |
| WO-2021198020-A1 | 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2021-10-07 | — | — | WO | claimed |
| WO-2020216781-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-10-29 | — | — | WO | claimed |
| WO-2013130660-A1 | AMIDES AS PIM INHIBITORS | AMGEN INC. (US) | 2013-09-06 | — | — | WO | claimed |
| EP-4055016-B1 | GPR52 MODULATOR COMPOUNDS | NXERA PHARMA UK LTD (GB) | 2026-04-29 | — | — | EP | disclosed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-4577537-A1 | SUBSTITUTED BICYCLES AS HSET INHIBITORS | Merck Patent GmbH (DE) | 2025-07-02 | — | — | EP | disclosed |
| WO-2004058762-A1 | MITOGEN ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE-2 INHIBITING COMPOUNDS | PHARMACIA CORPORATION (US) | 2004-07-15 | — | — | WO | disclosed |
| EP-1432708-A1 | PREPARATION AND USE OF 1,5,6,7-TETRAHYDROPYRROLO 3,2-C]PYRIDINE DERIVATIVES FOR TREATMENT OF OBESITY | Bayer Pharmaceuticals Corporation (US) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003027114-A1 | PREPARATION AND USE OF 1,5,6,7-TETRAHYDROPYRROLO[3,2-C]PYRIDINE DERIVATIVES FOR TREATMENT OF OBESITY | BAYER PHARMACEUTICALS CORPORATION (US) | 2003-04-03 | — | — | WO | disclosed |